UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 11, 2004
ATHEROGENICS, INC.
(Exact Name of Registrant as Specified in its Charter)
| Georgia | 0-31261 | 58-2108232 | ||
| (State or other jurisdiction | (Commission | (I.R.S. Employer | ||
| of incorporation) | File Number) | Identification Number) |
8995 Westside Parkway
Alpharetta, GA 30004
(Address of principal executive offices)
Registrant’s telephone number, including area code (678) 336-2500
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EX-99.1 PRESS RELEASE DATED FEBRUARY 11, 2004 | ||||||||
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
Exhibits.
The following exhibit is furnished as part of this current report on Form 8-K.
| Exhibit No. | Description | |||
| 99.1 | – | Press Release dated February 11, 2004 |
Item 12. Results of Operations and Financial Condition.
On February 11, 2004, AtheroGenics, Inc. issued a press release to report the company’s financial results for the quarter and year ended December 31, 2003. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ATHEROGENICS, INC | ||
| Date: February 11, 2004 | /s/ MARK P. COLONNESE | |
|
|
||
| Mark P. Colonnese | ||
| Senior Vice President of Finance and | ||
| Administration and Chief Financial Officer |
3
EXHIBIT INDEX
| Exhibit No. | Description | |||
| 99.1 | – | Press Release dated February 11, 2004 |
4